Dofequidar
Dofequidar (MS-209 free base) is an orally bioavailable quinoline-based compound that functions as a multidrug resistance (MDR) inhibitor by targeting efflux transporters such as ABCB1/P-gp and ABCC1/MRP1. It has been investigated in vitro and in vivo to sensitize cancer cells to chemotherapeutic agents and overcome treatment resistance.
Product Specifications
CAS Number
129716-58-1
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Smiles
O=C (N1CCN (CC1) CC (O) COC2=CC=CC3=NC=CC=C32) C (C=4C=CC=CC4) C=5C=CC=CC5
Molecular Formula
C30H31N3O3
Molecular Weight
481.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881471-100 1x 100 µL
Vitronectin Receptor / CD51 / CD61 (23C6), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041234-100 1x 100 µL
Bcl-2 (100/D5 + 124), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC473177-100 1x 100 µL
TAG-72 / CA72.4 (Tumor-Associated Glycoprotein) (rB72.3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880757-100 1x 100 µL
Cytokeratin 7 (K72.7), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042746-500 1x 500 µL
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741761-500 1x 500 µL
MART-1 / Melan-A / MLANA (Melanoma Marker) (MLANA/1761R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details